SBRA Sabra Health Care REIT Inc
- 14.415
- -0.095-0.65%
Sabra Health Care REIT Inc News
Sabra Healthcare REIT Is Maintained at Sector Perform by Scotiabank
Sabra Healthcare REIT Is Maintained at Sector Perform by Scotiabank
Scotiabank: Maintaining the Sabra Health Care REIT (SBRA.US) rating, adjusted from being flat with the market to being flat with the market, and the target price was adjusted from $14.00 to $15.00.
Scotiabank: Maintaining the Sabra Health Care REIT (SBRA.US) rating, adjusted from being flat with the market to being flat with the market, and the target price was adjusted from $14.00 to $15.00.
Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Raises Price Target to $15
Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT with a Sector Perform and raises the price target from $14 to $15.
Sabra Health Care REIT Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 1.9% Scotiabank $14 → $15 Maintains Sector Perform 01/30/2024 42.66% Deutsche Bank → $21 Initia
Sabra Health Care REIT Inc. Reports Q1 2024 Earnings: A Detailed Analysis
Sabra Health Care REIT Inc To Go Ex-Dividend On May 17th, 2024 With 0.3 USD Dividend Per Share
May 10th - $Sabra Health Care REIT Inc(SBRA.US)$ is trading ex-dividend on May 17th, 2024. Shareholders of record on May 20th, 2024 will receive 0.3 USD dividend per share on May 31st, 2024. The e
Sabra Health Care REIT Q1 Adjusted Funds From Operations, Revenue Rise
Sabra Health Care REIT (SBRA) reported late Wednesday Q1 adjusted funds from operations of $0.35 per diluted share, up from $0.34 a year earlier. Analysts polled by Capital IQ expected $0.34. Revenue
Sabra Health Care REIT Inc | 10-Q: Quarterly report
Sabra Health Care REIT Sees FY24 Normalized AFFO $1.39-$1.43
2024 GUIDANCESabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share):Net Income: $0.53 - $0.57FFO: $1.33 - $1.37Normalized FFO: $1
Sabra Health Care Reports Mixed Q1 Results; Reaffirms FY24 Outlook
Earnings Flash (SBRA) SABRA HEALTH CARE REIT Posts Q1 Revenue $166.7M
04:14 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (SBRA) SABRA HEALTH CARE REIT Posts Q1 Revenue $166.7M
Sabra Health Care REIT Q1 FFO $0.35 Beats $0.33 Estimate, Sales $166.75M Beat $159.88M Estimate
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.33 by 6.06 percent. This is a 2.94 percent increase over earnings of
Press Release: Sabra Reports First Quarter 2024 Results; Reiterates 2024 Guidance
Sabra Reports First Quarter 2024 Results; Reiterates 2024 Guidance TUSTIN, Calif.--(BUSINESS WIRE)--May 08, 2024-- Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (Nasdaq: SBRA) today
Sabra Healthcare REIT 1Q EPS 11c >SBRA
Sabra Healthcare REIT 1Q EPS 11c >SBRA
Sabra Healthcare REIT 1Q Rev $166.7M >SBRA
Sabra Healthcare REIT 1Q Rev $166.7M >SBRA
Sabra Healthcare REIT 1Q Net $26.3M >SBRA
Sabra Healthcare REIT 1Q Net $26.3M >SBRA
Sabra Health Care REIT, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2024 first quarter earnings release on May 8, 2024, after the close of trading. A conference call with a simultaneous webcast to
Deere, ASML, Steel Dynamics And A Real Estate Stock: CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said if you are looking for a stock that's on the verge of breaking out, Deere & Company (NYSE: DE). On March 25, Deere & C
CNBC Halftime Report Final Trades: Steel Dynamics, Sabra Health Care REIT, ASML Holding, Deere & Company
CNBC Halftime Report Final Trades: Steel Dynamics, Sabra Health Care REIT, ASML Holding, Deere & Company
Sabra Health Care REIT, Inc. to Attend the Deutsche Bank Inaugural Healthcare REIT Summit
TUSTIN, Calif.--(BUSINESS WIRE)--#DeutscheBank--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the compan
Analysis
Price Target
No Data
